EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic targeting of white adipose tissue metabolic dysfunction in obesity: mechanisms and opportunities

Zi-Han Yang iD, Fang-Zhou Chen, Yi-Xiang Zhang, Min-Yi Ou, Poh-Ching Tan, Xue-Wen Xu, Qing-Feng Li, Shuang-Bai Zhou iD

MedComm · 2024-06 · 5 (6)

DOI: 10.1002/mco2.560 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 24.05.2024. Verfasst von Zi-Han Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Burn Surgery West China Hospital of Sichuan University Chengdu China. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 292 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Innovative Research Team of High-level Local University in Shanghai.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

White adipose tissue is not only a highly heterogeneous organ containing various cells, such as adipocytes, adipose stem and progenitor cells, and immune cells, but also an endocrine organ that is highly important for regulating metabolic and immune homeostasis. In individuals with obesity, dynamic cellular changes in adipose tissue result in phenotypic switching and adipose tissue dysfunction, including pathological expansion, WAT fibrosis, immune cell infiltration, endoplasmic reticulum stress, and ectopic lipid accumulation, ultimately leading to chronic low‐grade inflammation and insulin resistance. Recently, many distinct subpopulations of adipose tissue have been identified, providing new insights into the potential mechanisms of adipose dysfunction in individuals with obesity. Therefore, targeting white adipose tissue as a therapeutic agent for treating obesity and obesity‐related metabolic diseases is of great scientific interest. Here, we provide an overview of white adipose tissue remodeling in individuals with obesity including cellular changes and discuss the underlying regulatory mechanisms of white adipose tissue metabolic dysfunction. Currently, various studies have uncovered promising targets and strategies for obesity treatment. We also outline the potential therapeutic signaling pathways of targeting adipose tissue and summarize existing therapeutic strategies for antiobesity treatment including pharmacological approaches, lifestyle interventions, and novel therapies.

Schlagwörter

Stichwörter der Autor:innen

adipose tissue remodelingimmunometabolic dysfunctionobesitysignaling pathwaystherapeutic potentials

Autor:innen und Institutionen

  • Department of Plastic and Burn Surgery West China Hospital of Sichuan University Chengdu China.
  • Department of Plastic & Reconstructive Surgery Shanghai Ninth People's Hospital Shanghai Jiao Tong University School of Medicine Shanghai China.

ORCID-Profile: Zi-Han Yang, Shuang-Bai Zhou

Förderung

  • National Natural Science Foundation of China
  • Innovative Research Team of High-level Local University in Shanghai

Zitieren

APA

Yang, Z. H., Chen, F. Z., Zhang, Y. X., Ou, M. Y., Tan, P. C., Xu, X. W., Li, Q. F., & Zhou, S. B. (2024). Therapeutic targeting of white adipose tissue metabolic dysfunction in obesity: mechanisms and opportunities. MedComm, 5(6). https://doi.org/10.1002/mco2.560

Vancouver

Yang ZH, Chen FZ, Zhang YX, Ou MY, Tan PC, Xu XW, et al. Therapeutic targeting of white adipose tissue metabolic dysfunction in obesity: mechanisms and opportunities. MedComm. 2024;5(6). doi:10.1002/mco2.560

BibTeX
@article{Yang2024,
  author = {Yang, Zi-Han and Chen, Fang-Zhou and Zhang, Yi-Xiang and Ou, Min-Yi and Tan, Poh-Ching and Xu, Xue-Wen and Li, Qing-Feng and Zhou, Shuang-Bai},
  title = {Therapeutic targeting of white adipose tissue metabolic dysfunction in obesity: mechanisms and opportunities},
  journal = {MedComm},
  year = {2024},
  volume = {5},
  number = {6},
  doi = {10.1002/mco2.560}
}
Kostenlos starten →